Eleven Therapeutics is a biotechnology company at the forefront of the artificial intelligence revolution in medicinal nucleic acids. The new generation of RNAi therapies is introduced by merging artificial intelligence, parallel functional testing, and combinatorial chemistry. SCSI-RNA is a programmable molecule that can be used to target anydisease or biological target of interest.

Biotechnology

Health Care

Therapeutics

Eleven Therapeutics

Yaniv Erlich

Adi Gilboa-Geffen

Shaul Ilan

Roei Pinhas

Omer Weissbrod

Iris Grossman, PhD

The Leadership Team at Eleven Therapeutics is responsible for setting the strategic direction, driving innovation in RNAi therapies, and overseeing the company’s operational and research initiatives. They ensure seamless integration of artificial intelligence and combinatorial chemistry into product development, while fostering collaborations and business development opportunities to advance therapeutic solutions.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Eleven Therapeutics

Research and Development